Patents by Inventor Steven Ruben
Steven Ruben has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20050129614Abstract: The present invention relates to antibodies and related molecules that specifically bind to TL5. Such antibodies have uses, for example, in the prevention and treatment of cancer as well as immune system diseases and disorders including autoimmune disease, rheumatoid arthritis, graft rejection, graft vs. host disease, and lymphadenopathy. The invention also relates to nucleic acid molecules encoding anti-TL5 antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same. The present invention relates to methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially cancer as well as immune system diseases and disorders including autoimmune disease, rheumatoid arthritis, graft rejection, graft vs.Type: ApplicationFiled: September 17, 2004Publication date: June 16, 2005Applicant: Human Genome Sciences, Inc.Inventors: Craig Rosen, Steven Ruben
-
Publication number: 20050129616Abstract: The present invention relates to antibodies and related molecules that immunospecifically bind to TRAIL receptor, TR4. Such antibodies have uses, for example, in the prevention and treatment of cancers and other proliferative disorders. The invention also relates to nucleic acid molecules encoding anti-TR4 antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same. The present invention relates to methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially cancer and other hyperproliferative disorders, comprising administering to an animal, preferably a human, an effective amount of one or more antibodies or fragments or variants thereof, or related molecules, that immunospecifically bind to TRAIL receptor TR4.Type: ApplicationFiled: November 12, 2004Publication date: June 16, 2005Applicant: Human Genome Sciences, Inc.Inventors: Theodora Salcedo, Steven Ruben, Craig Rosen, Vivian Albert
-
Publication number: 20050129699Abstract: The present invention relates to antibodies and related molecules that immunospecifically bind to TRAIL receptor, TR4i. Such antibodies have uses, for example, in the prevention and treatment of cancers and other proliferative disorders. The invention also relates to nucleic acid molecules encoding anti-TR4 antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same. The present invention relates to methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially cancer and other hyperproliferative disorders, comprising administering to an animal, preferably a human, an effective amount of one or more antibodies or fragments or variants thereof, or related molecules, that immunospecifically bind to TRAIL receptor TR4.Type: ApplicationFiled: November 12, 2004Publication date: June 16, 2005Applicant: Human Genome Sciences, Inc.Inventors: Theodora Salcedo, Steven Ruben, Craig Rosen, Vivian Albert
-
Publication number: 20050123961Abstract: Two human G-Protein coupled receptor polypeptides and DNA (RNA) encoding each of such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides. Also disclosed are diagnostic methods for detecting a mutation in the nucleic acid sequence of each of the G-protein coupled receptors.Type: ApplicationFiled: October 21, 2004Publication date: June 9, 2005Applicant: Human Genome Sciences, Inc.Inventors: Yi Li, Steven Ruben
-
Publication number: 20050118680Abstract: A human chemotactic polypeptide, DNA (RNA) encoding it, and a procedure for producing such a polypeptide by recombinant techniques are disclosed. Also disclosed are methods of using the polypeptide for a number of purposes, including: stem cell mobilization, myeloprotection, neuronal protection, treating tumors, wound healing, treating parasitic infection, and regulating hematopoiesis. Also disclosed are polypeptide antagonists and diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention for detecting diseases are also disclosed.Type: ApplicationFiled: January 18, 2005Publication date: June 2, 2005Applicant: Human Genome Sciences, Inc.Inventors: Haodong Li, Steven Ruben, Granger Sutton
-
Publication number: 20050095612Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.Type: ApplicationFiled: June 15, 2004Publication date: May 5, 2005Applicant: Human Genome Sciences, Inc.Inventors: Steven Ruben, Paul Young, Laurie Brewer, Reinhard Ebner, Henrik Olsen, Kimberly Florence, Craig Rosen, Roxanne Duan, Paul Moore, Yanggu Shi, David LaFleur, Charles Florence, Daniel Soppet, Gregory Endress, Ping Feng, George Komatsoulis
-
Publication number: 20050089911Abstract: The present invention relates to 87 novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.Type: ApplicationFiled: October 8, 2004Publication date: April 28, 2005Inventors: Paul Young, John Greene, Ann Ferrie, Steven Ruben, Craig Rosen, Roxanne Duan, Jing-Shan Hu, Kimberly Florence, Henrik Olsen, Reinhard Ebner, Laurie Brewer, Paul Moore, Yanggu Shi, David LaFleur, Jian Ni
-
Publication number: 20050089984Abstract: Human ICE LAP-6 polypeptides and DNA (RNA) encoding such ICE LAP-6 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such ICE LAP-6 for the treatment of a susceptibility to viral infection, tumorogenesis and to diseases and defects in the control embryogenesis and tissue homeostasis, and the nucleic acid sequences described above may be employed in an assay for ascertaining such susceptibility.Type: ApplicationFiled: October 12, 2004Publication date: April 28, 2005Inventors: Vishva Dixit, Wei-Wu He, Kristine Kikly, Steven Ruben
-
Publication number: 20050090436Abstract: The present invention relates to two novel proteins, TR21 and TR22, which are members of the tumor necrosis factor (TNF) receptor. In particular, isolated nucleic acid molecules are provided encoding the human TR21 and TR22 protein. TR21 and TR22 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TR21 and TR22 activity; and methods of treating immune disorders by administering TR21 and TR22 polynucleotides, polypeptides, agonists, and antagonists.Type: ApplicationFiled: July 17, 2003Publication date: April 28, 2005Applicant: Human Genome Sciences, Inc.Inventors: Zhizhen Zeng, Steven Ruben, Craig Rosen
-
Publication number: 20050079537Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.Type: ApplicationFiled: December 3, 2004Publication date: April 14, 2005Applicant: Human Genome Sciences, Inc.Inventors: David LaFleur, Steven Ruben, Craig Rosen, Paul Moore, Yanggu Shi, Hla Kyaw, Ying-Fei Wei
-
Publication number: 20050069943Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.Type: ApplicationFiled: November 3, 2004Publication date: March 31, 2005Applicant: Human Genome Sciences, Inc.Inventors: Roxanne Duan, Steven Ruben, Kimberly Florence, John Greene, Craig Rosen, Paul Young, Ann Ferrie, Guo-Liang Yu, Fouad Janat, Jian Ni, Kenneth Carter, Gregory Endress, Ping Feng, David LaFleur, Yanggu Shi
-
Publication number: 20050066529Abstract: A hand utensil for peeling and pitting a fruit, such as a mango, has a spoon-shaped bowl through which a plurality of elongated generally parallel slots laterally extend in a lower region of the concave surface between the proximal end and the distal end of the bowl. In addition, a series of arcuate ridges project from the concave surface of the bowl, wherein each arcuate ridge has a radius of curvature extending from a center point on a longitudinal axis defined by the bowl.Type: ApplicationFiled: September 30, 2003Publication date: March 31, 2005Inventor: Steven Ruben
-
Publication number: 20050065326Abstract: The present invention relates to antibodies and related molecules that specifically bind to TR2 proteins. Such antibodies have uses, for example, in the prevention and treatment of cancers and other proliferative disorders, autoimmune disorders, immunodeficiencies and/or HSV infection. The invention also relates to nucleic acid molecules encoding anti-TR2 antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same. The present invention relates to methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially cancer and other hyperproliferative disorders, comprising administering to an animal, preferably a human, an effective amount of one or more antibodies or fragments or variants thereof, or related molecules, that specifically bind to TR2.Type: ApplicationFiled: September 14, 2004Publication date: March 24, 2005Applicant: Human Genome Sciences, Inc.Inventors: Craig Rosen, Steven Ruben
-
Publication number: 20050064499Abstract: The present invention relates to PSGR, a novel prostate specific gene with homology to a G-protein coupled receptor overexpressed in prostate cancer. More specifically, the invention relates to PSGR polynucleotides and the polypeptides encoded by these polynucleotides, and the use of PSGR polynucleotides and polypeptides for detecting disorders of the reproductive system, including disorders of the prostate, particularly the presence of cancer. This invention relates to PSGR polynucleotides and polypeptides as well as vectors, host cells, antibodies directed to PSGR polynucleotides and polypeptides and recombinant and synthetic methods for producing the same. Also provided are methods for diagnosing, treating, preventing, and/or prognosing disorders related to the prostate, including cancer.Type: ApplicationFiled: October 20, 2004Publication date: March 24, 2005Applicant: Human Genome Sciences, Inc.Inventors: Daniel Soppet, Yi Li, Craig Rosen, Steven Ruben
-
Publication number: 20050064458Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.Type: ApplicationFiled: June 9, 2004Publication date: March 24, 2005Applicant: Human Genome Sciences, Inc.Inventors: Craig Rosen, Steven Ruben, Paul Moore, Paul Young, George Komatsoulis, Charles Birse, Roxanne Duan, Kimberly Florence, Daniel Soppet
-
Publication number: 20050059117Abstract: Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.Type: ApplicationFiled: November 4, 2004Publication date: March 17, 2005Applicant: Human Genome Sciences, Inc.Inventors: Craig Rosen, Vivian Albert, Steven Ruben, Ruth Wager
-
Publication number: 20050042667Abstract: The present invention relates to 36 novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.Type: ApplicationFiled: September 8, 2004Publication date: February 24, 2005Applicant: Human Genome Sciences, Inc.Inventors: David LaFleur, Daniel Soppet, Henrik Olsen, Steven Ruben, Jian Ni, Craig Rosen, Laurie Brewer, Roxanne Duan, Reinhard Ebner
-
Publication number: 20050037467Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.Type: ApplicationFiled: September 9, 2004Publication date: February 17, 2005Applicant: Human Genome Sciences, Inc.Inventors: Steven Ruben, Ping Feng, David LaFleur, Paul Moore, Yanggu Shi, Hla Kyaw, Yi Li, ZhiZhen Zeng, Kenneth Carter, Gregory Endress, Ying-Fei Wei, Ping Fan, Craig Rosen
-
Publication number: 20050037966Abstract: This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is a Keratinocyte Growth Factor, sometimes hereinafter referred to as “KGF-2” also formerly known as Fibroblast Growth Factor 12 (FGF-12). This invention further relates to the therapeutic use of KGF-2 to promote or accelerate wound healing. This invention also relates to novel mutant forms of KGF-2 that show enhanced activity, increased stability, higher yield or better solubility.Type: ApplicationFiled: July 29, 2004Publication date: February 17, 2005Applicant: Human Genome Sciences, Inc.Inventors: Steven Ruben, Pablo Jimenez, Roxanne Duan, Mark Rampy, Donna Mendrick, Jun Zhang, Jian Ni, Paul Moore, Timothy Coleman, Joachim Gruber, Patrick Dillon, Reiner Gentz
-
Publication number: 20050032168Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.Type: ApplicationFiled: July 23, 2004Publication date: February 10, 2005Applicant: Human Genome Sciences, Inc.Inventors: Craig Rosen, George Komatsoulis, Kevin Baker, Charles Birse, Daniel Soppet, Henrik Olsen, Paul Moore, Ping Wei, Reinhard Ebner, D. Duan, Yanggu Shi, Gil Choi, Michele Fiscella, Jian Ni, Steven Ruben, Steven Barash